68
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Unannounced telephone pill counts for assessing varenicline adherence in a pilot clinical trial

, , , , , & show all
Pages 475-482 | Published online: 28 Sep 2011

References

  • Smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 2000–2004MMWR Morb Mortal Wkly Rep200857451226122819008791
  • FioreMJaenCBakerTTreating Tobacco Use and Dependence Clinical Practice Guideline: 2008 UpdateWashington, DCUS Department of Health and Human Services2008 Available at: http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf
  • HaysJTLeischowSJLawrenceDLeeTCAdherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherenceNicotine Tob Res201012657458120457644
  • FishLJPetersonBLNamenek BrouwerRJAdherence to nicotine replacement therapy among pregnant smokersNicotine Tob Res200911551451819351783
  • MooneyMESayreSLHokansonPSStottsALSchmitzJMAdding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension studyAddict Behav200732487588016839698
  • ShiffmanSSweeneyCTFergusonSGSembowerMAGitchellJGRelationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokersClin Ther200830101852185819014840
  • CatzSLJackLMMcClureJBAdherence to varenicline in the COMPASS smoking cessation intervention trialNicotine Tob Res201113536136821350041
  • LeischowSJRanger-MooreJMuramotoMLMatthewsEEffectiveness of the nicotine inhaler for smoking cessation in an OTC settingAm J Health Behav200428429130115228966
  • NollenNLCoxLSNazirNA pilot clinical trial of varenicline for smoking cessation in Black smokersNicotine Tob Res2011 [Epub ahead of print.]
  • Nyfort-HansenKNMParthasarathiGNahataKMilapCA Text Book of Clinical Pharmacy Practice: Essential Concepts and SkillsHyderabad, IndiaOrient Blackswan2004
  • RuddyKMayerEPartridgeAPatient adherence and persistence with oral anticancer treatmentCA Cancer J Clin2009591566619147869
  • FarmerKCMethods for measuring and monitoring medication regimen adherence in clinical trials and clinical practiceClin Ther199921610741090 discussion 107310440628
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
  • Noncompliance with medication regimens. An economic tragedyEmerging issues in pharmaceutical cost containingWashington, DCNational Pharmaceutical Council1992116
  • KimHMLagakosSWAssessing drug compliance using longitudinal marker data, with application to AIDSStat Med19941319–20214121537846416
  • van OnzenoortHAWVerberkWJKesselsAGHAssessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertensionAm J Hypertens200923214915419927136
  • GrymonpreREDidurCDMontgomeryPRSitarDSPill count, self-report, and pharmacy claims data to measure medication adherence in the elderlyAnn Pharmacother1998327–87497549681089
  • BangsbergDRHechtFMCharleboisEDChesneyMMossAComparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill countsAIDS and Behavior200153275281
  • KalichmanSCAmaralCMCherryCMonitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validityHIV Clin Trials20089529830818977718
  • KalichmanSCAmaralCMStearnsHAdherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephoneJ Gen Intern Med20072271003100617390095
  • JorenbyDEHaysJTRigottiNAEfficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trialJAMA20062961566316820547
  • OkuyemiKSZhengHGuoHAhluwaliaJSPredictors of adherence to nicotine gum and counseling among African-American light smokersJ Gen Intern Med201025996997620495885
  • Cancer Prevention and Control Program University of California San DiegoThe California Tobacco Control Program: A Decade of Progress, Results from the California Tobacco Survey, 1990–1999; Final ReportLa Jolla, CACalifornia Department of Health Services Tobacco Control Section1999 Available from: http://libraries.ucsd.edu/ssds/pub/CTS/cpc00006/1999_Final_Report.pdfAccessed September 13, 2011
  • BushKKivlahanDRMcDonellMBFihnSDBradleyKAThe AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification TestArch Intern Med199815816178917959738608
  • GomezACondeASantanaHJorrinADiagnostic usefulness of briefer versions of alcohol use disorders identification test (AUDIT) for detecting hazardous drinkers in primary care settingsJ Stud Alcohol200566230530815957683
  • ColeJRabinASmithTKaufmanADevelopment and validation of a Rasch-derived CES-D short formPsychological Assessment200416436037215584795
  • AhluwaliaJSOkuyemiKNollenNThe effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial designAddiction2006101688389116696632
  • AhluwaliaJSHarrisKJCatleyDOkuyemiKSMayoMSSustained-release bupropion for smoking cessation in African Americans: a randomized controlled trialJAMA2002288446847412132977
  • ResnicowKJacksonAWangTA motivational interviewing intervention to increase fruit and vegetable intake through Black churches: results of the Eat for Life trialAm J Public Health200191101686169311574336
  • RollnickSButlerCStottNHelping smokers make decisions: The enhancement of brief interventions for general medical practicePatient Educ Couns19973131912039277242
  • AmrheinPCMillerWRYahneCEPalmerMFulcherLClient commitment language during motivational interviewing predicts drug use outcomesJ Consult Clin Psychol200371586287814516235
  • CatleyDGerkovichMWilliamsKGogginKA 4-item measure of motivation to adhere that predicts MEMS adherence over 48 weeksPaper presented at: NIMH/IAPAC International Conference on HIV Treatment Adherence2010, May 23–25Miami, FL
  • JohnsonMONeilandsTBDilworthSEMorinSFRemienRHChesneyMAThe role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)J Behav Med200730535937017588200
  • WallstonKMalcarneVFloresLDoes God determine your health? The God Locus of Health Control scaleCognitive Therapy and Research1999232131142
  • AubinHJBobakABrittonJRVarenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trialThorax200863871772418263663
  • GonzalesDRennardSINidesMVarenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trialJAMA20062961475516820546
  • NakamuraMOshimaAFujimotoYMaruyamaNIshibashiTReevesKREfficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokersClin Ther20072961040105617692720
  • NiauraRHaysJTJorenbyDEThe efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trialCurr Med Res Opin20082471931194118513462
  • NidesMOnckenCGonzalesDSmoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-upArch Intern Med2006166151561156816908788
  • OnckenCGonzalesDNidesMEfficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessationArch Intern Med2006166151571157716908789
  • TonstadSTonnesenPHajekPWilliamsKEBillingCBReevesKREffect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trialJAMA20062961647116820548
  • TsaiSTChoHJChengHSA randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokersClin Ther20072961027103917692719
  • WangCXiaoDChanKPPothiratCGarzaDDaviesSVarenicline for smoking cessation: a placebo-controlled, randomized studyRespirology200914338439219192221
  • MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
  • TollBAMcKeeSAMartinDJJatlowPO’MalleySSFactor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quitNicotine Tob Res20079559760517454716
  • BalmfordJBorlandRHammondDCummingsKMAdherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country SurveyNicotine Tob Res20111329410221147894
  • PetersenMLWangYvan der LaanMJGuzmanDRileyEBangsbergDRPillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysisClin Infect Dis200745790891517806060
  • SchoenthalerAOgedegbeGPatients’ perceptions of electronic monitoring devices affect medication adherence in hypertensive African AmericansAnn Pharmacother200842564765218397971